TikTok Content Creators Driving Parallel Market for Unapproved Slimming Drug
A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Treatment Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.
Active Commerce on Social Networks
Additionally, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and claims of rapid British shipping. Vendors market the drug there before directing buyers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Experts Express Concerns
However, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to users injecting products of uncertain source.
Several experts stated the demand for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for human use under the British medical regulations.
Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, advertising, and customer regulations, potentially leading to fines, legal action or imprisonment.
Platform Response and Material Elimination
Based on TikTok, the service has taken down violative material and prohibited related hashtags and search suggestions. The company said it was dedicated to maintaining the platform secure and allocating resources in strengthening compliance measures.
Online Marketplace Operations
Research also discovered groups with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, populated with photos of slimming results, positive testimonials and detailed guides for preparing or injecting at home.
Within minutes of entering one community, a vendor shared contact information, where the majority of transactions occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about body mass, medical conditions or previous experience.
Item Details and Pricing
Within these groups, messages show black plastic packages with Royal Mail stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically priced at £160 for 20 milligrams. When asked how long a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for Telegram said it regularly monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is sound, these online versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.
Her team has already seen individuals harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose patients to possibly significant health risks”.